Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NYSE - Delayed Quote USD

Bio-Rad Laboratories, Inc. (BIO-B)

Compare
241.99
0.00
(0.00%)
At close: March 31 at 11:42:11 AM EDT
Loading Chart for BIO-B
  • Previous Close 265.82
  • Open 241.99
  • Bid 237.65 x 900
  • Ask 240.10 x 800
  • Day's Range 241.99 - 241.99
  • 52 Week Range 241.99 - 359.22
  • Volume 4
  • Avg. Volume 41
  • Market Cap (intraday) 6.814B
  • Beta (5Y Monthly) 0.99
  • PE Ratio (TTM) --
  • EPS (TTM) -65.36
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

www.bio-rad.com

7,700

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BIO-B

View More

Performance Overview: BIO-B

Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BIO-B
25.68%
S&P 500 (^GSPC)
4.23%

1-Year Return

BIO-B
27.16%
S&P 500 (^GSPC)
7.42%

3-Year Return

BIO-B
58.81%
S&P 500 (^GSPC)
23.92%

5-Year Return

BIO-B
31.12%
S&P 500 (^GSPC)
128.01%

Compare To: BIO-B

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BIO-B

View More

Valuation Measures

Annual
As of 3/31/2025
  • Market Cap

    6.81B

  • Enterprise Value

    6.52B

  • Trailing P/E

    --

  • Forward P/E

    26.32

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.66

  • Price/Book (mrq)

    1.03

  • Enterprise Value/Revenue

    2.54

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -71.86%

  • Return on Assets (ttm)

    1.55%

  • Return on Equity (ttm)

    -24.09%

  • Revenue (ttm)

    2.57B

  • Net Income Avi to Common (ttm)

    -1.84B

  • Diluted EPS (ttm)

    -65.36

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.66B

  • Total Debt/Equity (mrq)

    20.93%

  • Levered Free Cash Flow (ttm)

    180.86M

Research Analysis: BIO-B

View More

Company Insights: BIO-B

Research Reports: BIO-B

View More

People Also Watch